Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Biomarker Study of Arsenic Trioxide for the Treatment of Patients With Basal Cell Carcinoma

NCT01791894 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01791894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01791894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Biomarker Study of Arsenic Trioxide for the Treatment of Patients With Basal Cell Carcinoma
Lead sponsor
Stanford University
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2013
Completion date
November 30, 2015
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma of the skin, recurrent skin cancer